Comparison results
Results: Differences Similar | ✘Carotenodermy | ✘CLC syndrome | |||||||
Related research | Analogs | Analogs | |||||||
| |||||||||
Distinctive symptoms | |||||||||
Register, to see more distinctive signs of diseases and studies | 100% | — | |||||||
Register, to see more distinctive signs of diseases and studies | — | 57% | |||||||
yellow skin color | 40% | — | |||||||
chronic condition | — | 38% | |||||||
jaundice | 30% | — | |||||||
tachycardia attacks | — | 31% | |||||||
follicular hyperkeratosis | 30% | — | |||||||
qrs interval duration lowered | — | 30% | |||||||
palms yellow | 29% | — | |||||||
wolf-parkinson-white syndrome | — | 28% | |||||||
dry skin peeling | 28% | — | |||||||
rheumatic mycarditis | — | 28% | |||||||
oily skin | 28% | — | |||||||
left atrium volume decreased | — | 25% | |||||||
nasolabial folds | 28% | — | |||||||
tachycardia | — | 24% | |||||||
due to excessive intake of energy resources | 26% | — | |||||||
palpitations | — | 23% | |||||||
skin color | 26% | — | |||||||
heart dysfunction | — | 21% | |||||||
scurvy | 23% | — | |||||||
IBS | — | 19% | |||||||
vitamin c reduced | 23% | — | |||||||
supraventricular tachycardia | — | 19% | |||||||
adaptation disorders | 23% | — | |||||||
atrioventricular block | — | 18% | |||||||
fat deposits | 23% | — | |||||||
acute expansion of the heart | — | 18% | |||||||
hyperkeratosis | 23% | — | |||||||
weak heart | — | 17% | |||||||
peeling | 22% | — | |||||||
parkinson's disease | — | 17% | |||||||
dry skin | 21% | — | |||||||
rheumatism | — | 17% | |||||||
liver failure | 20% | — | |||||||
enlargement of the thyroid gland | — | 16% | |||||||
obesity | 19% | — | |||||||
nervous excitability | — | 16% | |||||||
liver problems | 17% | — | |||||||
arterial hypertension in adults | — | 16% | |||||||
dryness | 17% | — | |||||||
take it, take it | — | 16% | |||||||
skin problems | 16% | — | |||||||
hyperthyroidism | — | 16% | |||||||
beriberi | 28% | 15% | |||||||
diffuse toxic goiter | — | 16% | |||||||
volume of thyroid gland is reduced | 24% | 18% | |||||||
thyrotoxicosis | — | 16% | |||||||
thyroid diseases | 20% | 15% | |||||||
enlargement of the heart | — | 15% | |||||||
hormonal disorders | 17% | 13% | |||||||
myocardial infarction | — | 15% | |||||||
cardiodilation | — | 15% | |||||||
hypertension | — | 14% | |||||||
arrhythmia | — | 14% | |||||||
paralysis | — | 14% | |||||||
hypertension | — | 13% | |||||||
necrosis | — | 13% | |||||||
damage to the nervous system | — | 12% | |||||||
impaired arterial function | — | 12% | |||||||
there are no complaints | — | 12% |
Instructions
Video
|